{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T03:18:16Z","timestamp":1648696696229},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13052-016-0239-6","type":"journal-article","created":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T05:06:55Z","timestamp":1457500015000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Changes of serum aspergillus galactomannan during hematopoietic stem cell transplantation in children with prior invasive aspergillosis"],"prefix":"10.1186","volume":"42","author":[{"given":"Te-Fu","family":"Weng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang-Hsi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Ping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Tien","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Hua","family":"Chao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,9]]},"reference":[{"key":"239_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","volume":"34","author":"S Ascioglu","year":"2002","unstructured":"Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34:7\u201314.","journal-title":"Clin Infect Dis"},{"key":"239_CR2","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","volume":"50","author":"DP Kontoyiannis","year":"2010","unstructured":"Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis. 2010;50:1091\u2013100.","journal-title":"Clin Infect Dis"},{"key":"239_CR3","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.3727\/096368912X663533","volume":"22","author":"KH Wu","year":"2013","unstructured":"Wu KH, Tsai C, Wu HP, Sieber M, Peng CT, Chao YH. Human application of ex vivo expanded umbilical cord-derived mesenchymal stem cells: enhance hematopoiesis after cord blood transplantation. Cell Transplant. 2013;22:2041\u201351.","journal-title":"Cell Transplant"},{"key":"239_CR4","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3727\/096368912X655217","volume":"22","author":"KH Wu","year":"2013","unstructured":"Wu KH, Wu HP, Chan CK, Hwang SM, Peng CT, Chao YH. The role of mesenchymal stem cells in hematopoietic stem cell transplantation: from bench to bedsides. Cell Transplant. 2013;22:723\u20139.","journal-title":"Cell Transplant"},{"key":"239_CR5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bbmt.2004.02.006","volume":"10","author":"T Fukuda","year":"2004","unstructured":"Fukuda T, Boeckh M, Guthrie KA, Mattson DK, Owens S, Wald A, et al. Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center. Biol Blood Marrow Transplant. 2004;10:494\u2013503.","journal-title":"Biol Blood Marrow Transplant"},{"key":"239_CR6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/mmy\/myv026","volume":"53","author":"A Ambasta","year":"2015","unstructured":"Ambasta A, Carson J, Church DL. The use of biomarkers and molecular methods for the earlier diagnosis of invasive aspergillosis in immunocompromised patients. Med Mycol. 2015;53:531\u201357.","journal-title":"Med Mycol"},{"key":"239_CR7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0140-6736(95)91273-8","volume":"346","author":"NS Young","year":"1995","unstructured":"Young NS. Aplastic anaemia. Lancet. 1995;346:228\u201332.","journal-title":"Lancet"},{"key":"239_CR8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1053\/j.seminhematol.2009.03.008","volume":"46","author":"JM Valdez","year":"2009","unstructured":"Valdez JM, Scheinberg P, Young NS, Walsh TJ. Infections in patients with aplastic anemia. Semin Hematol. 2009;46:269\u201376.","journal-title":"Semin Hematol"},{"key":"239_CR9","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/339202","volume":"34","author":"KA Marr","year":"2002","unstructured":"Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infection in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2002;34:909\u201317.","journal-title":"Clin Infect Dis"},{"key":"239_CR10","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1399-3046.2008.01056.x","volume":"13","author":"A Al-Rezqi","year":"2009","unstructured":"Al-Rezqi A, Hawkes M, Doyle J, Richardson SE, Allen U. Invasive mold infections in iatrogenically immunocompromised children: an eight-yr review. Pediatr Transplant. 2009;13:545\u201352.","journal-title":"Pediatr Transplant"},{"key":"239_CR11","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1007\/s00520-013-1844-1","volume":"21","author":"M Markov\u00e1","year":"2013","unstructured":"Markov\u00e1 M, Brodsk\u00e1 H, Mal\u00ed\u010dkov\u00e1 K, V\u00e1lkov\u00e1 V, Cetkovsk\u00fd P, Kol\u00e1\u0159 M, et al. Substantially elevated C-reactive protein (CRP), together with low levels of procalcitonin (PCT), contributes to diagnosis of fungal infection in immunocompromised patients. Support Care Cancer. 2013;21:2733\u201342.","journal-title":"Support Care Cancer"},{"key":"239_CR12","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1097\/INF.0b013e3182905d83","volume":"32","author":"HL Sun","year":"2013","unstructured":"Sun HL, Wu KH, Chen SM, Chao YH, Ku MS, Hung TW, et al. Role of procalcitonin in predicting dilating vesicoureteral reflux in young children hospitalized with a first febrile urinary tract infection. Pediatr Infect Dis J. 2013;32:e348\u2013e54.","journal-title":"Pediatr Infect Dis J"},{"key":"239_CR13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","volume":"46","author":"TJ Walsh","year":"2008","unstructured":"Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:327\u201360.","journal-title":"Clin Infect Dis"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-016-0239-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T07:57:09Z","timestamp":1498291029000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ijponline.net\/content\/42\/1\/30"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,9]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["239"],"URL":"https:\/\/doi.org\/10.1186\/s13052-016-0239-6","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,9]]},"article-number":"30"}}